% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Hemminki:272839,
      author       = {K. Hemminki$^*$ and F. Tichanek and A. Försti$^*$ and O.
                      Hemminki and A. Hemminki},
      title        = {{S}urvival in gastric and esophageal cancers in the
                      {N}ordic countries through a half century.},
      journal      = {Cancer medicine},
      volume       = {12},
      number       = {9},
      issn         = {2045-7634},
      address      = {Hoboken, NJ},
      publisher    = {Wiley},
      reportid     = {DKFZ-2023-00412},
      pages        = {10212-10221},
      year         = {2023},
      note         = {#EA:C020# / 2023 May;12(9):10212-10221},
      abstract     = {Gastric cancer (GC) and esophageal cancer (EC) are among
                      the most fatal cancers and improving survival in them is a
                      major clinical challenge. Nordic cancer data were recently
                      released up to year 2019. These data are relevant for
                      long-term survival analysis as they originate from
                      high-quality national cancer registries from countries with
                      practically free access to health care, thus documenting
                      'real-world' experience for entire populations.Data were
                      obtained for Danish (DK), Finnish (FI), Norwegian (NO), and
                      Swedish (SE) patients from the NORDCAN database from years
                      1970 through 2019. Relative 1- and 5-year survival were
                      analyzed, and additionally the difference between 1- and
                      5-year survival was calculated as a measure of trends
                      between years 1 and 5 after diagnosis.Relative 1-year
                      survival for Nordic men and women in GC was $30\%$ in period
                      1970-74 and it increased close to $60\%.$ Early 5-year
                      survival ranged between 10 and $15\%$ and the last figures
                      were over $30\%$ for all women and NO men while survival for
                      other men remain below $30\%.$ Survival in EC was below that
                      in GC, and it reached over $50\%$ for 1-year survival only
                      for NO patients; 5-year survival reached over $20\%$ only
                      for NO women. For both cancers, the difference between 1-
                      and 5-year survival increased with time. Survival was worst
                      among old patients.GC and EC survival improved over the
                      50-year period but the increase in 5-year survival was
                      entirely explained by gains in 1-year survival, which
                      improved at an accelerated pace in EC. The likely reasons
                      for improvements are changes in diagnosis, treatment, and
                      care. The challenges are to push survival past year 1 with
                      attention to old patients. These cancers have a potential
                      for primary prevention through the avoidance of risk
                      factors.},
      keywords     = {mortality (Other) / relative survival (Other) / risk
                      factors (Other) / stomach cancer (Other) / treatment
                      (Other)},
      cin          = {C020 / B062 / HD01},
      ddc          = {610},
      cid          = {I:(DE-He78)C020-20160331 / I:(DE-He78)B062-20160331 /
                      I:(DE-He78)HD01-20160331},
      pnm          = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
      pid          = {G:(DE-HGF)POF4-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:36846972},
      doi          = {10.1002/cam4.5748},
      url          = {https://inrepo02.dkfz.de/record/272839},
}